Anzeige
Mehr »
Donnerstag, 30.04.2026 - Börsentäglich über 12.000 News
250 Tage bis zum Pentagon-Magnetverbot: Wie ein 46-Mio.-CAD-Small-Cap profitieren könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiPfizer protects $6.4bn heart disease blockbuster from generics, for now
MiEli Lilly bets on recombinases in $2.25bn Profluent R&D pact
MiNovartis' Q1 sales miss hints at industry's utilisation of M&A remedies
MiArcera and Fosun sign MoU for neuroscience innovation
MiRocket to sell PRV for $180m to advance gene therapy pipeline
DiMerck KGaA and Remepy join forces to develop combo drug-digital therapies
DiSeaport and Hemab target $180m IPOs as biotech listings accumulate
DiBioMarin acquires Amicus Therapeutics for $4.8bn
DiFDA approves AstraZeneca's Saphnelo for SLE
MoEli Lilly outlays $2.3bn to acquire blood cancer specialist Ajax Therapeutics
MoNovartis secures pair of regulatory wins for skin disease and malaria treatments
MoUK biotech could be bound for recovery, BIA report reveals
MoSun Pharma to acquire Organon for $11.75bn
FrRegulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings
FrOZMOSI and Planview partner to enhance pharmaceutical data integration
FrRegeneron cuts White House pricing deal, offers new gene therapy for free
FrCumberland to sell drug portfolio to Apotex for $100m
23.04.500,000 patients' data for sale online after UK Biobank breach
23.04.Sanofi receives FDA approval for Tzield in paediatric diabetes
23.04.AbbVie opts for North Carolina to house $1.4bn manufacturing site
23.04.MSD teams up with Google Cloud on agentic AI transformation
22.04.Medicare weight loss drug pilot on ice as insurers decline to contribute
22.04.MSD-backed Ray locks in $125m to back eye drug pipeline
22.04.FDA approves MSD's once-daily HIV combo Idvynso
22.04.BioAegis and Prenosis partner for inflammatory disease therapies